Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

20 Mar 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral gastroenteritis research and epidemiology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33794143
DOI: 10.1016/j.cell.2021.03.036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesPMID 33794143Read ↗

SARS-CoV-2 variant biology: immune escape, transmission and fitnessSemantic proximity Read ↗

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccinationSemantic proximity Read ↗

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.Semantic proximity Read ↗

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodiesSemantic proximity Read ↗

Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients.Semantic proximity Read ↗

SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanismsSemantic proximity Read ↗

Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.Semantic proximity Read ↗

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsSemantic proximity Read ↗

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeSemantic proximity Read ↗

Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.Semantic proximity Read ↗

New mutations raise specter of ‘immune escape’Semantic proximity Read ↗

Epidemiological characteristics of three SARS-CoV-2 variants of concern and implications for future COVID-19 pandemic outcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.